(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

Baxter 2B0040 - Dextrose Injection, 5% USP, 50 ml, Mini-Bag Plus Container, Quad Pack, 80/cs (Rx) (Continental US Only, Excluding IN and ND)

Baxter # 2B0040 - Dextrose Injection, 5% USP, 50 ml, Mini-Bag Plus Container, Quad Pack, 80/cs (Rx) (Continental US Only, Excluding IN and ND)
Part Number Baxter 2B0040
SKU Number CIA8043440
Sell Unit CASE
Ships Within Special Order
List Price $819.70
Enter a valid quantity
Product Description

Baxter 2B0040 - Dextrose Injection, 5% USP, 50 ml, Mini-Bag Plus Container, Quad Pack, 80/cs (Rx) (Continental US Only, Excluding IN and ND)

Baxter 2B0040 Premasol (Amino Acid), Sulfite-Free, 10% Injection, 500 ml

5% Dextrose Injection, USP in the MINI-BAG Plus Container is a sterile, nonpyrogenic solution for intravenous administration after admixture with a single dose powdered drug. It contains no antimicrobial agents. Each 100 mL contains 5 g of Dextrose Hydrous, USP. The osmolarity is 252 m0smol/L (calculated). The pH is 4.0 (3.2 to 6.5). The chemical structure for Dextrose Hydrous, USP is shown below.

The MINI-BAG Plus Container is a standard diluent container with an integral drug vial adaptor. It allows for drug admixture after connection to a single dose powdered drug vial having a 20 mm closure. A breakaway seal in the tube between the vial adaptor and the container is broken to allow transfer of the diluent into the vial and reconstitution of the drug. The reconstituted drug is then transferred from the vial into the container diluent and mixed to result in an admixture for delivery to the patient.

The VIAFLEX plastic container is fabricated from polyvinyl chloride (PL 146 Plastic). Exposure to temperatures above 25 degree celsius /77 degree fahrenheit during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.

Indications and Usage for Dextrose Injection Mini-Bag

5% Dextrose Injection, USP is indicated as a source of water and calories and may also be used as diluent for reconstitution of a powdered drug product packaged in a vial with a 20 mm closure.

Dextrose Injection Mini-Bag Dosage and Administration

Dosage is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

All injections in MINI-BAG Plus Containers are intended for intravenous administration using sterile equipment.

Do not remove unit from overwrap until ready for use. The overwrap is a moisture barrier.

Related Products